Polar Capital Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.73M | Hold |
|
|||||
|
2024
Q3 | $2.3M | Sell |
|
|||||
|
2024
Q2 | $84.1M | Sell |
|
|||||
|
2024
Q1 | $107M | Sell |
|
|||||
|
2023
Q4 | $110M | Buy |
|
|||||
|
2023
Q3 | $36.6M | Sell |
|
|||||
|
2023
Q2 | $35.4M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $20.8M | Hold |
|
|||||
|
2022
Q3 | $18.5K | Sell |
|
|||||
|
2022
Q2 | $76.5K | Buy |
|
|||||
|
2022
Q1 | $71.2K | Buy |
|
|||||
|
2021
Q4 | $2.92K | Buy |
|
|||||
|
2021
Q3 | $2.86K | Sell |
|
|||||
|
2021
Q2 | $16K | Buy |
|
|||||
|
2021
Q1 | $12.5M | Buy |
|
|||||
|
2020
Q4 | $11.8M | Buy |
|